Cargando…

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors

Bryostatin-1 belongs to the family of macrocyclic lactones isolated from the marine bryozoan Bugula neritina and is a potent activator of protein kinase C (PKC). Bryostatin has been demonstrated to possess both in vivo and in vitro anti-leukaemic potential. In samples derived from chronic myeloid le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thijsen, S F T, Schuurhuis, G J, Oostveen, J W van, Theijsmeijer, A P, van der Hem, K G, Odding, J H, Dräger, A M, Ossenkoppele, G J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362710/ https://www.ncbi.nlm.nih.gov/pubmed/10188883 http://dx.doi.org/10.1038/sj.bjc.6690225

Ejemplares similares

Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space
por: Akinduro, O., et al.
Publicado: (2018)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
por: Blackhall, F H, et al.
Publicado: (2001)

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.
por: Prendiville, J., et al.
Publicado: (1994)

CDK-inhibitor independent cell cycle progression in an experimental haematopoietic stem cell leukaemia despite unaltered Rb-phosphorylation
por: Huss, R, et al.
Publicado: (1999)

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
por: Basilico, Silvia, et al.
Publicado: (2017)

Avian leukaemia viruses and haematopoietic cell differentiation.
por: Graf, T., et al.
Publicado: (1980)

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma
por: Saso, R, et al.
Publicado: (2000)

Hypermethylation of the FANCC and FANCL Promoter Regions in Sporadic Acute Leukaemia
por: Hess, C. J., et al.
Publicado: (2008)

Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells()
por: Olme, C.-H., et al.
Publicado: (2013)

Indoor residential radon exposure and risk of childhood acute myeloid leukaemia
por: Steinbuch, M, et al.
Publicado: (1999)

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
por: Hanekamp, Diana, et al.
Publicado: (2020)

Infections, vaccinations, and the risk of childhood leukaemia
por: Dockerty, J D, et al.
Publicado: (1999)

p53 status of newly established acute myeloid leukaemia cell lines
por: Zheng, A, et al.
Publicado: (1999)

Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
por: Bai, Lu, et al.
Publicado: (2022)

Bryostatin analog: improving on Nature's design
por: Boger, Dale
Publicado: (2012)

Tobacco and the risk of acute leukaemia in adults
por: Kane, E V, et al.
Publicado: (1999)

Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus
por: Grigoriou, Maria, et al.
Publicado: (2020)

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.
por: Thompson, C. H., et al.
Publicado: (1996)

Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity
por: Klein, J-L D, et al.
Publicado: (1999)

A phase II study of bryostatin 1 in metastatic malignant melanoma.
por: Propper, D. J., et al.
Publicado: (1998)

Munc13 Is a Molecular Target of Bryostatin 1
por: Blanco, Francisco A., et al.
Publicado: (2019)

AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML
por: Hanekamp, Diana, et al.
Publicado: (2021)

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia
por: Zhu, Y-M, et al.
Publicado: (1999)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
por: Gratwohl, Alois, et al.
Publicado: (2019)

Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice
por: Dawar, Swati, et al.
Publicado: (2016)

Requirements for human haematopoietic stem/progenitor cells
por: Nan, Xue, et al.
Publicado: (2021)

Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
por: Balduzzi, Adriana, et al.
Publicado: (2022)

Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors
por: Piekarska, Agnieszka, et al.
Publicado: (2016)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups
por: Moorman, A V, et al.
Publicado: (2002)

Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA
por: Groves, F D, et al.
Publicado: (1999)

Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases
por: Hoogeveen, Renate M, et al.
Publicado: (2018)

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
por: Prendiville, J., et al.
Publicado: (1993)

Bryostatin-1: a promising compound for neurological disorders
por: Tian, Zhen, et al.
Publicado: (2023)

A pooled analysis of magnetic fields and childhood leukaemia
por: Ahlbom, A, et al.
Publicado: (2000)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival
por: Verhagen, H JMP, et al.
Publicado: (2014)

Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
por: Sargent, J M, et al.
Publicado: (2001)

A Case of Myeloid Leukæmia
por: Ghosal, J. N.
Publicado: (1931)

Cannot write session to /tmp/vufind_sessions/sess_tvh102ddc8ta87g3u8u03u2lgr